Spyre Therapeutics Cash Flow Statement (2015-2026) | SYRE

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M-62.53M-69.00M-36.20M
Share-based Compensation (Quarter)
2.11M2.09M2.10M2.02M7.11M1.70M1.90M4.80M181.34M13.80M8.70M13.10M-35.60M8.86M9.38M0.30M9.81M12.81M13.51M
Cash from Operations (Quarter)
-17.00M-19.27M-26.26M-20.67M-15.07M-18.14M-17.63M-16.64M-34.60M-31.04M-28.54M-62.25M-29.42M-37.20M-40.99M-46.56M-37.12M-44.58M-57.37M-69.88M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.15M-0.06M-0.01M0.04M0.15M0.15M0.11M0.02M0.49M1.71M2.42M3.56M3.00M2.42M2.64M2.01M1.35M2.08M2.06M3.09M
Amortization of Deferred Charges (Quarter)
0.09M0.10M0.10M0.10M0.16M0.06M
Depreciation & Amortization (CF) (Quarter)
0.41M0.41M0.40M0.38M0.40M0.39M0.38M0.36M
Change in Working Capital
Change in Receivables (Quarter)
0.81M0.20M-0.53M0.19M-0.29M-0.04M1.32M-1.48M-0.16M
Change in Account Payables (Quarter)
-0.34M1.46M-0.34M-1.01M1.35M1.38M0.66M-4.16M-0.29M-6.51M8.84M-17.47M-0.84M3.02M0.02M0.32M4.87M0.04M0.03M
Change in Accured Expenses (Quarter)
1.04M0.46M-3.14M2.26M-0.42M0.45M-3.16M2.11M-2.94M-0.89M8.15M-15.77M7.37M14.87M-6.00M-2.30M4.41M3.12M3.65M-3.43M
Other Working Capital Changes (Quarter)
-1.40M-6.81M-0.77M-0.15M0.62M-0.58M-0.20M-0.10M0.87M
Investing Activities
Capital Expenditures (Quarter)
0.09M0.04M0.00M-2.07M
Sales of Property, Plant and Equipment (Quarter)
0.50M
Change in Intangibles (Quarter)
7.00M30.00M40.00M
Change in Acquisitions & Divestments (Quarter)
32.12M22.91M29.30M25.00M23.75M18.50M17.75M3.25M18.90M47.75M57.88M77.79M62.55M71.38M106.87M99.19M94.30M107.75M109.44M
Cash from Investing Activities (Quarter)
5.78M9.66M25.76M0.75M16.50M14.00M17.75M6.76M-97.63M-35.27M-104.96M-120.52M42.74M-170.54M-0.06M79.00M25.00M-247.41M56.58M-297.90M
Financing Activities
Other financing activities (Quarter)
1.25M0.25M0.18M0.04M0.02M0.10M0.28M4.39M164.68M-162.87M-6.20M0.22M0.85M0.49M-1.56M2.68M432.56M
Change in Capital Stock
Shares Issued (Quarter)
6.61M10.13M
Net Equity Issued and Repurchased (Quarter)
197.36M169.21M-0.14M-157.31M
Misc.
Cash from Financing Activities (Quarter)
1.14M0.08M0.01M42.80M-0.13M-0.01M0.01M209.99M-12.53M163.61M172.16M0.36M12.78M225.60M0.12M0.73M-4.64M312.81M12.26M432.60M
Exchange Rate Effect (Quarter)
-0.03M0.00M-0.02M-0.07M-0.06M0.05M0.01M0.01M-0.02M0.02M-0.00M0.02M-0.01M
Change in Cash (Quarter)
-10.11M-9.52M-0.52M22.81M1.24M-4.10M0.14M200.12M-144.78M97.32M38.66M-182.41M26.11M17.84M-40.93M33.17M-16.76M20.82M11.46M64.82M
Free Cash Flow (Quarter)
-17.09M-19.27M-26.30M-20.67M-15.07M-18.14M-17.63M-16.64M-32.53M-31.04M-28.54M-62.25M-29.42M-37.20M-40.99M-46.56M-37.12M-44.58M-57.37M-69.88M
Net Cash Flow (Quarter)
-10.08M-9.53M-0.49M22.88M1.30M-4.15M0.13M200.11M-144.76M97.30M38.66M-182.41M26.10M17.86M-40.93M33.17M-16.76M20.82M11.46M64.82M